Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 7:56 PM
Ignite Modification Date:
2025-12-25 @ 5:31 PM
NCT ID:
NCT01111604
Group ID:
EG001
Title:
mFOLFOX-6 + Ramucirumab
Description:
mFOLFOX-6 + Ramucirumab
Ramucirumab : 8 mg/kg I.V. infusion, administered every 2 weeks
mFOLFOX-6: Oxaliplatin: 85 mg/m² I.V. infusion q2 weeks
FA: 400 mg/m² I.V. infusion q2 weeks (or LFA: 200 mg/m2 q2 weeks if FA is unavailable).
5FU: 400 mg/m² bolus + 2400 mg/m² I.V. infusion q2 weeks
Deaths Number Affected:
41
Deaths Number At Risk:
None
Serious Number Affected:
18
Serious Number At Risk:
52
Other Number Affected:
52
Other Number At Risk:
52
Study:
NCT01111604
Results Section:
NCT01111604
Adverse Events Module:
NCT01111604